January 10, 2012Open Access

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

TVTina VilsbøllUniversity of Copenhagen MCMikkel ChristensenUniversity of Copenhagen AJAnders JunkerInterventional Cardiology

Key Points

Key points are not available for this paper at this time.

Abstract

The present review provides evidence that treatment with GLP-1R agonists leads to weight loss in overweight or obese patients with or without type 2 diabetes mellitus.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Vilsbøll et al. (Tue,) studied this question.

synapsesocial.com/papers/695c4b7403da22d857ec866b https://doi.org/https://doi.org/10.1136/bmj.d7771

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)1998 · 20,093 citations
2Funding, disease area, and internal validity of hepatobiliary randomized clinical trials2002 · 30 citations
3Long-term Prevention of Mortality in Morbid Obesity Through Bariatric Surgery. A Systematic Review and Meta-analysis of Trials Performed With Gastric Banding and Gastric Bypass2011 · 258 citations
4Body Mass Index, Prostate Cancer–Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis2011 · 487 citations
5Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus2005 · 351 citations

Demander à l'IA

Bookmark

View Full Paper